Bottom line
How much do IYH and JDOC overlap?
60% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 60.8% of IYH's assets and 51.2% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings IYH and JDOC have in common
| Holding | % of IYH | % of JDOC | Overlap |
|---|---|---|---|
| Eli Lilly And Company | 15.11% | 7.76% | 7.76% |
| Johnson & Johnson | 10.17% | 4.82% | 4.82% |
| Abbvie Inc. | 7.32% | 7.85% | 7.32% |
| Unitedhealth Group Incorporated | 6.16% | 5.85% | 5.85% |
| Merck & Co., Inc. | 5.31% | 4.82% | 4.82% |
| Thermo Fisher Scientific Incorporated | 3.52% | 3.73% | 3.52% |
| Abbott Laboratories | 3.02% | 3.11% | 3.02% |
| Bristol-myers Squibb Company | 2.20% | 3.57% | 2.20% |
| Intuitive Surgical, Inc. | 2.05% | 1.93% | 1.93% |
| Danaher Corporation | 2.03% | 2.16% | 2.03% |
| Stryker Corporation | 1.86% | 2.23% | 1.86% |
| Regeneron Pharmaceuticals, Inc. | 1.27% | 1.60% | 1.27% |
| Edwards Lifesciences Corporation | 0.81% | 1.73% | 0.81% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IYH
- Amgen Inc. — 3.42%
- Gilead Sciences, Inc. — 2.66%
- Pfizer Inc. — 2.35%
- Vertex Pharmaceuticals Incorporated — 2.00%
- Medtronic Public Limited Company — 1.80%
- Elevance Health, Inc. — 1.34%
- The Cigna Group — 1.20%
- Boston Scientific Corporation — 1.14%
- Hca Healthcare, Inc. — 0.99%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 0.80%
- Becton, Dickinson And Company — 0.78%
- Idexx Laboratories, Inc. — 0.73%
Only in JDOC
- AstraZeneca plc — 3.76%
- CVS Health Corp. — 2.83%
- Roche Holding AG — 2.82%
- Novo Nordisk A/S — 2.61%
- GSK plc — 2.47%
- Cencora, Inc. — 2.07%
- Argenx SE — 2.06%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Novartis AG — 1.60%
- Biogen, Inc. — 1.56%
- Cardinal Health, Inc. — 1.51%
Asset mix
| Asset type | IYH | JDOC |
|---|---|---|
| Stocks | 99.8% | 99.2% |
| Cash & short-term funds | 0.9% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | IYH | JDOC |
|---|---|---|
| US | 97.3% | 75.2% |
| GB | 0.4% | 6.2% |
| CH | — | 4.4% |
| DK | 0.2% | 4.0% |
| JP | — | 2.5% |
| IE | 2.4% | 0.4% |
| NL | 0.1% | 2.4% |
| DE | — | 1.9% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do IYH and JDOC overlap?
What stocks do IYH and JDOC have in common?
Should I own both IYH and JDOC?
Which holds more stocks, IYH or JDOC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.